Phase I trial of gemcitabine and vinorelbine in patients with refractory solid tumors: efficacy with minimal toxicity in a geriatric population

被引：0
|
作者：
Radice, P [1 ]
Koletsky, A [1 ]
Greenhawt, M [1 ]
Frankel, C [1 ]
Pearce, P [1 ]
Byrne, C [1 ]
Jahanzeb, M [1 ]
机构：
[1] Interctr Ctr Canc Res Grp, Palm Beach, FL USA
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [1] A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumors
    Nancy W. Peacock
    Howard A. Burris
    Veronique Dieras
    Lon Smith
    Gladys I. Rodriguez
    John R. Eckardt
    Suzanne Fields Jones
    Joanne Hardy
    John Hohneker
    Joseph Bigley
    Daniel D. Von Hoff
    Investigational New Drugs, 1998, 16 : 37 - 43
  • [2] A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumors
    Peacock, NW
    Burris, HA
    Dieras, V
    Smith, L
    Rodriguez, GI
    Eckardt, JR
    Jones, SF
    Hardy, J
    Hohneker, J
    Bigley, J
    Von Hoff, DD
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (01) : 37 - 43
  • [3] A phase I trial of gemcitabine plus paclitaxel combination therapy in patients with refractory solid tumors
    Sandler, A
    Raghavan, D
    Meropol, N
    Meyers, T
    Kindler, H
    Fox, S
    Perez, R
    Einhorn, LH
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1120 - 1120
  • [4] Irinotecan and gemcitabine in patients with solid tumors: Phase I trial
    Lima, CMSR
    Leong, SS
    Sherman, CA
    Perkel, JA
    Putman, T
    Safa, AR
    Green, MR
    ONCOLOGY-NEW YORK, 2002, 16 (05): : 19 - 24
  • [5] A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors
    Ghalib, Mohammad H.
    Pulla, Mariano Provencio
    Luken, Maria J. De Miguel
    de Juan, Virginia Calvo
    Chaudhary, Imran
    Hammami, M. Bakri
    Vikash, Sindhu
    Maitra, Radhashree
    Martinez, Sara
    Kahatt, Carmen
    Extremera, Sonia
    Fudio, Salvador
    Goel, Sanjay
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (05) : 481 - 491
  • [6] Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors
    Rothenberg, ML
    Sharma, A
    Weiss, GR
    Villalona-Calero, MA
    Eckardt, JR
    Aylesworth, C
    Kraynak, MA
    Rinaldi, DA
    Rodriguez, GI
    Burris, HA
    Eckhardt, SG
    Stephens, CD
    Forral, K
    Nicol, SJ
    Von Hoff', DD
    ANNALS OF ONCOLOGY, 1998, 9 (07) : 733 - 738
  • [7] Phase I trial of everolimus, gemcitabine and cisplatin for patients with solid tumors refractory to standard therapy.
    Costello, Brian Addis
    Qi, Yingwei
    Borad, Mitesh J.
    Kim, George P.
    Northfelt, Donald W.
    Erlichman, Charles
    Alberts, Steven R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
    Brell, Joanna M.
    Krishnamurthi, Smitha S.
    Rath, Linda
    Bokar, Joseph A.
    Savvides, Panayiotis
    Gibbons, Joseph
    Cooney, Matthew M.
    Meropol, Neal J.
    Ivy, Percy
    Dowlati, Afshin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 547 - 553
  • [9] Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors
    William, William N., Jr.
    Lee, Joseph L.
    Shin, Dong M.
    Hong, Waun K.
    Liu, Suyu
    Lee, J. Jack
    Lippman, Scott M.
    Khuri, Fadlo R.
    Kim, Edward S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 15 - 19
  • [10] Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors
    Brian A. Costello
    Mitesh J. Borad
    Yingwei Qi
    George P. Kim
    Donald W. Northfelt
    Charles Erlichman
    Steven R. Alberts
    Investigational New Drugs, 2014, 32 : 710 - 716
12345